Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
Trump Says Anthropic No Longer Seen as National Security Threat 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
SAN CLEMENTE, Calif., Jan. 22, 2016 -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its fourth quarter and fiscal year 2015 earnings release conference call.
The Company will release its fourth quarter and full year 2015 results at approximately 4:00 p.m. EST (1:00 p.m. PST) and will be conducting a conference call concerning those results at 4:30 p.m. EST (1:30 p.m. PST) on Wednesday, February 3, 2016. The call can be accessed at (800) 936-9761, international (408) 774-4587, conference ID 34390619. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical technologies used in infusion therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. The Company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, closed blood sampling systems, and hemodynamic monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit the Company's website at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott Lamb, Chief Financial Officer (949) 366-2183 ICR, Inc. John Mills, Partner (646) 277-1254
